Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
CTSH
REST API REST API
Homo sapiens
CTSH is differentially expressed in 299 experiments: 117 organism parts: lung, kidney, ... (115 more);, 185 disease states: normal, cervical carcinoma, ... (183 more);, 113 cell types 530 cell lines 37 compound treatments and 75 other conditions.
Synonyms ACC-5, ACC-4, CPSB
Orthologs Ctsh (Mus musculus)   ctsh (Danio rerio)   F1P3U9_CHICK (Gallus gallus)   CATH_BOVIN (Bos taurus)   F6WXG6_CIOIN (Ciona intestinalis)   Ctsh (Rattus norvegicus)   CTSH (Canis familiaris)   (Compare orthologs)
InterPro Term Peptidase_C1A_C, Prot_inhib_I29
Gene Ontology Term protein binding, lysosome, peptidase activity, cysteine-type endopeptidase activity, proteolysis, cysteine-type peptidase activity, kininogen binding, dichotomous subdivision of terminal units involved in lung branching, protein destabilization, response to retinoic acid, positive regulation of epithelial cell migration
UniProt Accession P09668, Q68D46, E9PN60, E9PN84, E9PBP2, E9PF73, E9PKT6
Search EB-eye ENSG00000103811
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-803, E-GEOD-6573, E-GEOD-2549, E-GEOD-3526, E-MTAB-62, ... (28 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-3860, E-GEOD-17482, E-GEOD-5258, E-GEOD-4525, E-GEOD-19639, ... (45 experiments)

Factor Value U/D Experiments
MCF-7
3
E-GEOD-19639, E-GEOD-20081, E-GEOD-3529
SW480
3
E-MTAB-37, E-GEOD-18005, E-MEXP-1014
A549
2
E-GEOD-3202, E-GEOD-6013
Daudi
2
E-MTAB-37, E-GEOD-96
Jurkat
2
E-MEXP-2197, E-GEOD-1880
MDA468
2
E-MEXP-440, E-MTAB-62
524 more value(s).


Cell type

studied in E-GEOD-20193, E-GEOD-21612, E-GEOD-21668, E-GEOD-3920, E-MEXP-750, ... (57 experiments)

Factor Value U/D Experiments
CD8+ T cell
4
E-AFMX-5, E-GEOD-6740, E-GEOD-19069, E-MTAB-25
endothelial cell
2
E-GEOD-3920, E-GEOD-3998
CD14+ monocyte
1
2
E-AFMX-5, E-MEXP-1600, E-TABM-145
parental
1
E-GEOD-21612
whole blood
1
E-MTAB-25
iPS cells from episomal vectors (Defined Factor sub-clone)
1
E-GEOD-20033
107 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-15960, E-GEOD-2466, E-GEOD-1577, E-TABM-15, ... (58 experiments)

Factor Value U/D Experiments
adrenocortical carcinoma
2
E-TABM-311, E-GEOD-10927
colon carcinoma
2
E-MTAB-62, E-MTAB-37
control
2
E-GEOD-21912, E-GEOD-20602
gastric carcinoma
2
E-GEOD-15460, E-MTAB-37
neuroblastoma
2
E-MTAB-37, E-MTAB-62
prostate carcinoma
2
E-MTAB-62, E-GEOD-7307
179 more value(s).


Compound treatment

studied in E-GEOD-4668, E-GEOD-6907, E-GEOD-5741, E-GEOD-15205, E-GEOD-697, ... (22 experiments)

Factor Value U/D Experiments
TNF
1
E-GEOD-15205
control - interferon-gamma
1
E-GEOD-7216
lipopolysaccharide
1
E-MEXP-1958
actinomycin D
1
E-GEOD-6400
control for heregulin
1
E-GEOD-6462
U0126
1
E-GEOD-697
31 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
DMSO
1
E-GEOD-19519
thapsigargin
1
E-GEOD-19519


Biopsy tissue
studied in E-GEOD-5851

BioSourceProvider
studied in E-GEOD-19466, E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Cancer site
studied in E-GEOD-4271

Cell treatment
studied in E-MEXP-1192

Cellular component
studied in E-GEOD-1400

Clinical history
studied in E-GEOD-22097, E-GEOD-19420, E-TABM-234, E-GEOD-19743, E-GEOD-7967, ... (8 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-MEXP-1251, E-GEOD-21374, E-GEOD-21589, ... (7 experiments)

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

development stage
studied in E-GEOD-22601

Developmental stage
studied in E-GEOD-6236, E-GEOD-4667, E-GEOD-3891, E-MEXP-2283, E-MTAB-62 ... (5 experiments)

dfs time (months)
studied in E-GEOD-21653

Disease stage
studied in E-GEOD-7463

Disease staging
studied in E-GEOD-89, E-GEOD-19743, E-GEOD-3325, E-TABM-577, E-GEOD-22148, ... (6 experiments)

Environmental stress
studied in E-GEOD-1518, E-GEOD-3720

Er
studied in E-GEOD-20194, E-GEOD-16716

Estrogen receptor status
studied in E-GEOD-6532

Ethnic group
studied in E-GEOD-20194, E-GEOD-16716

Ethnicity
studied in E-GEOD-16363

family id
studied in E-GEOD-19519

Family relationship
studied in E-MEXP-1425

Genetic modification
studied in E-GEOD-7578, E-GEOD-17385, E-GEOD-20847, E-MEXP-2340, E-MEXP-563 ... (5 experiments)

Genotype
studied in E-GEOD-2466, E-GEOD-21750, E-MEXP-421, E-GEOD-22593, E-GEOD-20115, ... (9 experiments)

Gestation age
studied in E-GEOD-14334

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-TABM-263, E-GEOD-13073, E-MEXP-1446, E-GEOD-22278, E-GEOD-837, ... (9 experiments)

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234, E-GEOD-16194, E-TABM-276

Individual
studied in E-TABM-325, E-MTAB-197, E-MEXP-2069, E-GEOD-1926, E-MEXP-1648, ... (36 experiments)

Infection
studied in E-GEOD-12108

Injury
studied in E-GEOD-19743

Karyotype
studied in E-GEOD-22056

Labeling
studied in E-LGCL-5

Light
studied in E-GEOD-1725

Lymph node status
studied in E-GEOD-6532

Material type
studied in E-GEOD-9171

Media
studied in E-MEXP-765, E-GEOD-21612

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Molecular subtype
studied in E-GEOD-21653

Nbefore
studied in E-GEOD-20194, E-GEOD-16716

organ
studied in E-GEOD-24283

Organism
studied in E-GEOD-1801, E-AFMX-1, E-GEOD-426, E-TABM-84

Organism status
studied in E-GEOD-19188

Performer
studied in E-LGCL-5

Phenotype
studied in E-GEOD-19703, E-GEOD-1309, E-GEOD-21750, E-GEOD-17636, E-GEOD-2487, ... (7 experiments)

Protocol type
studied in E-GEOD-22097, E-GEOD-19246

Replicate
studied in E-GEOD-18791, E-GEOD-10896

RNAi
studied in E-MEXP-1509, E-GEOD-1676, E-MEXP-1857

Sample preparation
studied in E-GEOD-16728

Sample type
studied in E-TABM-783

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743, E-GEOD-17400

Sex
studied in E-GEOD-19069, E-GEOD-2466, E-GEOD-7307

Sirna
studied in E-GEOD-21575

Stimulation
studied in E-GEOD-20114, E-GEOD-11428

stimulus
studied in E-GEOD-22103

Strain or line
studied in E-MEXP-1996

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-19188

Tbefore
studied in E-GEOD-20194, E-GEOD-16716

Test result
studied in E-GEOD-1926

Tissue
studied in E-GEOD-30573

Treatment
studied in E-GEOD-16837, E-GEOD-21909, E-GEOD-19246, E-GEOD-13818, E-GEOD-19815, ... (6 experiments)

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-89, E-TABM-147

Vehicle
studied in E-GEOD-5258

Processing time: 0.54 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM